Despite its high expression in inflamed lesions of individuals with IBD, IL-33 exhibits a dual role in animal models of intestinal inflammation, influencing Th2 responses, Th1 inflammation, mucosal regeneration, and fibrosis [130]. This evidence concerns the gene IL33 and inflammatory bowel disease.